Published in Science on August 21, 1992
Political refutation of a scientific theory: the case of polio vaccines and the origin of AIDS. Health Care Anal (1998) 0.81
Possible origins of AIDS. Science (1992) 1.40
Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genet (1979) 7.28
Activation of production of infectious tumor virus SV40 in heterokaryon cultures. Proc Natl Acad Sci U S A (1967) 6.05
Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus. Proc Natl Acad Sci U S A (1983) 4.54
Chromosomal location of the genes for human immunoglobulin heavy chains. Proc Natl Acad Sci U S A (1979) 4.52
Production of antibodies against influenza virus by somatic cell hybrids between mouse myeloma and primed spleen cells. Proc Natl Acad Sci U S A (1977) 4.30
Study of antibodies against human melanoma produced by somatic cell hybrids. Proc Natl Acad Sci U S A (1978) 4.24
A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II. J Biol Chem (1982) 3.97
Specific antigen in serum of patients with colon carcinoma. Science (1981) 3.68
Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. Proc Natl Acad Sci U S A (1979) 3.46
Expression of rabies virus glycoprotein from a recombinant vaccinia virus. Nature (1984) 3.32
Comparison of the ribonucleic acid polymerases of two rhabdoviruses, Kern Canyon virus and vesicular stomatitis virus. J Virol (1971) 3.26
Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin. Cancer Res (1983) 3.15
Monoclonal antibodies against rabies virus produced by somatic cell hybridization: detection of antigenic variants. Proc Natl Acad Sci U S A (1978) 3.03
Antigenic properties of rabies virus components. J Immunol (1973) 2.68
Purification of rabies virus grown in tissue culture. J Virol (1968) 2.67
Effect of polyions on the infectivity of rabies virus in tissue culture: construction of a single-cycle growth curve. J Virol (1967) 2.67
New assay procedure for separation of mycoplasmas from virus pools and tissue culture systems. J Virol (1967) 2.64
Assignment of the T-antigen gene of simian virus 40 to human chromosome C-7. Proc Natl Acad Sci U S A (1973) 2.63
Detection of serum antibodies to Borna disease virus in patients with psychiatric disorders. Science (1985) 2.57
Isolation of latent herpes simplex virus from the superior cervical and vagus ganglions of human beings. N Engl J Med (1978) 2.55
Antigenic variants of rabies virus. J Exp Med (1980) 2.51
Successful protection of humans exposed to rabies infection. Postexposure treatment with the new human diploid cell rabies vaccine and antirabies serum. JAMA (1976) 2.47
Herpes simplex type 1 DNA in human brain tissue. Proc Natl Acad Sci U S A (1981) 2.45
Structural proteins of rabies virus. J Virol (1971) 2.42
Effect of environmental pH on the efficiency of cellular hybridization. Proc Natl Acad Sci U S A (1972) 2.39
Repertoire of antiviral antibodies expressed by somatic cell hybrids. Proc Natl Acad Sci U S A (1978) 2.38
Production of human hybridomas secreting antibodies to measles virus. Nature (1980) 2.32
Immune lysis of rabies virus-infected cells. J Immunol (1968) 2.25
Phase-I clinical trial of monoclonal antibody in treatment of gastrointestinal tumours. Lancet (1982) 2.25
Influenza virus hemagglutinin-specific antibodies isolated from a combinatorial expression library are closely related to the immune response of the donor. Proc Natl Acad Sci U S A (1990) 2.24
Amplification and molecular cloning of HTLV-I sequences from DNA of multiple sclerosis patients. Science (1989) 2.23
Molecular recognition and the future of monoclonal antibodies. Nature (1982) 2.22
Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci U S A (1998) 2.21
Gastrointestinal cancer-associated antigen in immunoperoxidase assay. Cancer Res (1982) 2.21
Antigenic analysis of rabies and Mokola virus from Zimbabwe using monoclonal antibodies. Dev Biol Stand (1984) 2.20
Presence of 2 different viral agents in brain cells of patients with subacute sclerosing panencephalitis. Proc Soc Exp Biol Med (1970) 2.20
Early events in the infection of permissive cells with simian virus 40: adsorption, penetration, and uncoating. J Virol (1970) 2.18
Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system. J Virol (1998) 2.15
IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells. Proc Natl Acad Sci U S A (1982) 2.15
Morphology of the nucleoprotein component of rabies virus. J Virol (1968) 2.13
Molecular mimicry in virus infection: crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments. Proc Natl Acad Sci U S A (1983) 2.12
Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein expression in infected primary neuron cultures. J Virol (1999) 2.04
Laboratory techniques in rabies. Mouse inoculation test. Monogr Ser World Health Organ (1966) 2.04
Induction and biological properties of defective interfering particles of rabies virus. J Virol (1977) 2.02
Virus particles in early mouse embryos. J Natl Cancer Inst (1973) 2.02
A monosialoganglioside is a monoclonal antibody-defined antigen of colon carcinoma. Science (1981) 2.02
Differences in cell-to-cell spread of pathogenic and apathogenic rabies virus in vivo and in vitro. J Virol (1985) 2.00
Structure and development of rabies virus in tissue culture. J Virol (1967) 2.00
Cell-mediated cytotoxicity against virus-infected target cells in humans. II. Interferon induction and activation of natural killer cells. J Immunol (1978) 1.99
Immunogenicity of concentrated and purified rabies vaccine of tissue culture origin. Proc Soc Exp Biol Med (1969) 1.99
Multiple sclerosis and human T-cell lymphotropic retroviruses. Nature (1985) 1.96
Use of hybridoma monoclonal antibodies in the detection of antigenic differences between rabies and rabies-related virus proteins. II. The glycoprotein. J Gen Virol (1980) 1.96
Characterization of a unique variant of bat rabies virus responsible for newly emerging human cases in North America. Proc Natl Acad Sci U S A (1996) 1.95
Molecular mimicry: frequency of reactivity of monoclonal antiviral antibodies with normal tissues. J Virol (1986) 1.95
Gene transfer and molecular cloning of the human NGF receptor. Science (1986) 1.91
Somatic cell hybrids between mouse peritoneal macrophages and SV40-transformed human cells. I. Positive control of the transformed phenotype by the human chromosome 7 carrying the SV40 genome. J Exp Med (1974) 1.91
Biochemical and biophysical studies on the nucleocapsid and on the RNA of rabies virus. Virology (1969) 1.90
Mechanisms of activation of human natural killer cells against tumor and virus-infected cells. Immunol Rev (1979) 1.88
The polypeptide and the DNA restriction enzyme profiles of spontaneous isolates of herpes simplex virus type 1 from explants of human trigeminal, superior cervical and vagus ganglia. J Gen Virol (1979) 1.86
Effective protection of monkeys against death from street virus by post-exposure administration of tissue-culture rabies vaccine. Bull World Health Organ (1971) 1.85
Human regulatory gene for inducible tyrosine aminotransferase in rat-human hybrids. Proc Natl Acad Sci U S A (1973) 1.84
Human macrophages armed with murine immunoglobulin G2a antibodies to tumors destroy human cancer cells. Science (1983) 1.78
Rabies virus quasispecies: implications for pathogenesis. Proc Natl Acad Sci U S A (1998) 1.77
Induction of protective immunity against rabies by immunization with rabies virus ribonucleoprotein. Proc Natl Acad Sci U S A (1987) 1.76
Monoclonal antibody detection of a circulating tumor-associated antigen. I. Presence of antigen in sera of patients with colorectal, gastric, and pancreatic carcinoma. J Clin Immunol (1982) 1.76
Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis. FASEB J (2000) 1.75
Molecular cloning and characterization of an antigen associated with early stages of melanoma tumor progression. Cancer Res (1988) 1.72
Spontaneous cell-mediated cytotoxicity in humans: role of interferon and immunoglobulins. J Immunol (1978) 1.71
Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody. Cancer Res (1980) 1.70
Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc Natl Acad Sci U S A (1995) 1.70
Unidirectional loss of human chromosomes in rat-human hybrids. Exp Cell Res (1973) 1.69
Genetically determined resistance to infection with group B arboviruses. II. Increased production of interfering particles in cell cultures from resistant mice. J Infect Dis (1974) 1.67
Laboratory techniques in rabies: the mouse inoculation test. Monogr Ser World Health Organ (1973) 1.64
Growth characteristics of virus-transformed cells. Maximum population density, inhibition by normal cells, serum requirement, growth in soft agar, and xenogeneic transplantability. J Exp Med (1970) 1.63
Properties of hybrids between polyoma-transformed and normal mouse cells. Proc Natl Acad Sci U S A (1967) 1.63
In vitro evidence of cell-mediated immunity after exposure of mice to both live and inactivated rabies virus. Proc Natl Acad Sci U S A (1977) 1.63
Subacute sclerosing panencephalitis: structures resembling myxovirus nucleocapsids in cells cultured from brain. Nature (1969) 1.62
Biology of tumor progression in human melanocytes. Lab Invest (1987) 1.61
Comparison of subacute sclerosing panencephalitis and measles viruses: an electron microscope study. J Virol (1971) 1.61
Delineation of putative mechanisms involved in antibody-mediated clearance of rabies virus from the central nervous system. Proc Natl Acad Sci U S A (1992) 1.60
Oral immunization and protection of raccoons (Procyon lotor) with a vaccinia-rabies glycoprotein recombinant virus vaccine. Proc Natl Acad Sci U S A (1986) 1.60
Hemagglutination by rabies virus. J Virol (1968) 1.60
Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and colorectal carcinoma. Eur J Immunol (1979) 1.59
Borna disease virus-specific antibodies in patients with HIV infection and with mental disorders. Lancet (1988) 1.57
Molecular cloning of cDNA for the carcinoma-associated antigen GA733-2. Proc Natl Acad Sci U S A (1990) 1.57
Preferential retention of the human chromosome C-7 in human-(thymidine kinase deficient) mouse hybrid cells. Exp Cell Res (1973) 1.57
Anti-idiotypic antibodies induce neutralizing antibodies to rabies virus glycoprotein. J Virol (1983) 1.57
Genetically determined resistance to infection with group B arboviruses. I. Distribution of the resistance gene among various mouse populations and characteristics of gene expression in vivo. J Infect Dis (1974) 1.55
Concordant segregation of the expression of SV40 T antigen and human chromosome 7 in mouse-human hybrid subclones. J Exp Med (1974) 1.55
Fusion of cultured multiple-sclerosis brain cells with indicator cells: presence of nucleocapsids and virions and isolation of parainfluenza-type virus. Lancet (1972) 1.55
Direct entry of rabies virus into the central nervous system without prior local replication. J Virol (1991) 1.54
Antibody-directed cytotoxic agents: use of monoclonal antibody to direct the action of toxin A chains to colorectal carcinoma cells. Proc Natl Acad Sci U S A (1980) 1.54
Human melanoma cell lines of primary and metastatic origin express the genes encoding the chains of platelet-derived growth factor (PDGF) and produce a PDGF-like growth factor. Proc Natl Acad Sci U S A (1986) 1.54
HLA-related control of spontaneous and antibody-dependent cell-mediated cytotoxic activity in humans. J Immunol (1976) 1.54
Characterization of saturable binding sites for rabies virus. J Virol (1984) 1.53
Human anti-idiotype antibodies in cancer patients: Is the modulation of the immune response beneficial for the patient? Proc Natl Acad Sci U S A (1984) 1.52
Retroviral sequences related to human T-lymphotropic virus type II in patients with chronic fatigue immune dysfunction syndrome. Proc Natl Acad Sci U S A (1991) 1.51
Radioimmunoassay procedure for rabies binding antibodies. J Immunol (1972) 1.49
Evidence for intergenic complementation in hybrid cells derived from two human diploid strains each carrying an X-linked mutation. Proc Natl Acad Sci U S A (1969) 1.48
Response of simian virus 40-transformed cell lines and cell hybrids to superinfection with simian virus 40 and its deoxyribonucleic acid. J Virol (1969) 1.47